Publications

Educators

April 1993 (Revised February 1996)
Supplement

ALZA and Bio-Electro Systems (B1): Rights Offering Strategy

By: Josh Lerner and Peter Tufano

Supplements the (A) case. Describes the CEO's decision. View Details

Keywords: Strategy; Intellectual Property

April 1993 (Revised February 1996)
Supplement

ALZA and Bio-Electro Systems (B2): The Rights Offering

By: Josh Lerner and Peter Tufano

Supplements the (A) case. Describes the implementation of the CEO's decision. View Details

Keywords: Intellectual Property

April 1993 (Revised February 1996)
Supplement

ALZA and Bio-Electro Systems (C): 1988-92

By: Josh Lerner and Peter Tufano

Supplements the (A) case. Describes the aftermarket performance of the units. View Details

Keywords: Performance

March 1993 (Revised May 1998)
Teaching Note

ImmuLogic Pharmaceutical Corporation (Series) TN

Teaching Note for (9-293-066--071) and (9-293-087). View Details

Keywords: Pharmaceutical Industry

1993
Article

Innovation and the Structure of High-Technology Industries

Keywords: Innovation and Invention; Information Technology; Business Ventures

Find at Harvard

December 1992 (Revised September 1996)
Case

ImmuLogic Pharmaceutical Corporation (Abridged)

ImmuLogic Pharmaceutical Corp., a development-stage biotechnology company, is considering making an initial offering of common stock. The rationales for and problems of high-technology start-ups are explored. The challenges posed by "windows" for public offerings are... View Details

Keywords: Decisions; Initial Public Offering; Entrepreneurship; Going Public; Business Startups; Biotechnology Industry; Pharmaceutical Industry; United States

Educators

October 1992 (Revised November 1997)
Case

ImmuLogic Pharmaceutical Corporation (A): March 1991

ImmuLogic Pharmaceutical Corp., a development-stage biotechnology company, is considering making an initial offering of common stock. The diverse perspectives of the entrepreneur, venture capitalist, investment banker, and institutional investor are explored. Problems... View Details

Keywords: Decisions; Entrepreneurship; Venture Capital; Banks and Banking; Initial Public Offering; Going Public; Perspective; Valuation; Biotechnology Industry; Pharmaceutical Industry

Educators

October 1992 (Revised March 1993)
Supplement

ImmuLogic Pharmaceutical Corporation (B1): Malcolm Gefter

Supplements the (A) case. View Details

Keywords: Pharmaceutical Industry

October 1992 (Revised April 1993)
Supplement

ImmuLogic Pharmaceutical Corporation (B2): Henry McCance

Supplements the (A) case. View Details

Keywords: Pharmaceutical Industry

October 1992 (Revised March 1993)
Supplement

ImmuLogic Pharmaceutical Corporation (B3): Katherine Kirk

Supplements the (A) case. View Details

Keywords: Pharmaceutical Industry

October 1992 (Revised April 1993)
Supplement

ImmuLogic Pharmaceutical Corporation (B4): Phillip Gross

Supplements the (A) case. View Details

Keywords: Pharmaceutical Industry

October 1992 (Revised March 1993)
Supplement

ImmuLogic Pharmaceutical Corporation (C): April 1991

Supplements the (A) case. View Details

Keywords: Pharmaceutical Industry

Teaching Interest

Owner/President Management Progam (Executive Education)

As business owners and entrepreneurs prepare to take their companies to the next level in a highly competitive global arena, they must be fully equipped to master a range of skills—from strategy development to financial management to team... View Details

Teaching Interest

Private Equity and Venture Capital (Executive Education)

As equity markets appear to strengthen, interest rates remain low, and asset values look attractive, private equity firms are uniquely positioned to pursue new opportunities. This View Details

Teaching Interest

Theoretical and Empirical Perspectives on Entrepreneurship (Doctoral)

Entrepreneurship—the formation and growth of new firms—is a complex phenomenon that has historically attracted relatively little academic attention. In recent years, however, scholars in a variety of disciplines have been devoting increasing attention to this topic.... View Details

Teaching Interest

Venture Capital and Private Equity (MBA)